vs
RHYTHM PHARMACEUTICALS, INC.（RYTM）与null（SWIM）财务数据对比。点击上方公司名可切换其他公司
null的季度营收约是RHYTHM PHARMACEUTICALS, INC.的1.7倍（$100.0M vs $57.3M），null净利率更高（-7.0% vs -83.0%，领先76.0%），RHYTHM PHARMACEUTICALS, INC.同比增速更快（36.9% vs 14.5%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（48.5% vs -4.9%）
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
该企业是一家源自美国的跨国律师事务所，1934年创立于加利福尼亚州洛杉矶，在诉讼业务、公司法务以及监管合规法律领域拥有深厚的行业积累与知名度，是全球颇具影响力的综合性律所之一。
RYTM vs SWIM — 直观对比
营收规模更大
SWIM
是对方的1.7倍
$57.3M
营收增速更快
RYTM
高出22.3%
14.5%
净利率更高
SWIM
高出76.0%
-83.0%
两年增速更快
RYTM
近两年复合增速
-4.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $57.3M | $100.0M |
| 净利润 | $-47.5M | $-7.0M |
| 毛利率 | 91.6% | 28.0% |
| 营业利润率 | -82.2% | -10.7% |
| 净利率 | -83.0% | -7.0% |
| 营收同比 | 36.9% | 14.5% |
| 净利润同比 | -9.6% | 76.0% |
| 每股收益（稀释后） | $-0.73 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RYTMSWIM
| Q4 25 | $57.3M | $100.0M | ||
| Q3 25 | $51.3M | $161.9M | ||
| Q2 25 | $48.5M | $172.6M | ||
| Q1 25 | $32.7M | $111.4M | ||
| Q4 24 | $41.8M | $87.3M | ||
| Q3 24 | $33.3M | $150.5M | ||
| Q2 24 | $29.1M | $160.1M | ||
| Q1 24 | $26.0M | $110.6M |
净利润RYTMSWIM
| Q4 25 | $-47.5M | $-7.0M | ||
| Q3 25 | $-52.9M | $8.1M | ||
| Q2 25 | $-46.6M | $16.0M | ||
| Q1 25 | $-49.5M | $-6.0M | ||
| Q4 24 | $-43.3M | $-29.2M | ||
| Q3 24 | $-43.6M | $5.9M | ||
| Q2 24 | $-32.3M | $13.3M | ||
| Q1 24 | $-141.4M | $-7.9M |
毛利率RYTMSWIM
| Q4 25 | 91.6% | 28.0% | ||
| Q3 25 | 89.3% | 35.4% | ||
| Q2 25 | 88.6% | 37.1% | ||
| Q1 25 | 88.8% | 29.5% | ||
| Q4 24 | 90.9% | 24.6% | ||
| Q3 24 | 88.5% | 32.4% | ||
| Q2 24 | 89.9% | 33.1% | ||
| Q1 24 | 89.2% | 27.7% |
营业利润率RYTMSWIM
| Q4 25 | -82.2% | -10.7% | ||
| Q3 25 | -102.6% | 13.3% | ||
| Q2 25 | -93.4% | 14.3% | ||
| Q1 25 | -143.7% | -4.4% | ||
| Q4 24 | -98.6% | -14.9% | ||
| Q3 24 | -132.0% | 8.9% | ||
| Q2 24 | -139.2% | 12.5% | ||
| Q1 24 | -538.7% | -1.9% |
净利率RYTMSWIM
| Q4 25 | -83.0% | -7.0% | ||
| Q3 25 | -103.1% | 5.0% | ||
| Q2 25 | -96.1% | 9.3% | ||
| Q1 25 | -151.4% | -5.4% | ||
| Q4 24 | -103.6% | -33.4% | ||
| Q3 24 | -131.2% | 3.9% | ||
| Q2 24 | -110.9% | 8.3% | ||
| Q1 24 | -544.4% | -7.1% |
每股收益（稀释后）RYTMSWIM
| Q4 25 | $-0.73 | $-0.06 | ||
| Q3 25 | $-0.82 | $0.07 | ||
| Q2 25 | $-0.75 | $0.13 | ||
| Q1 25 | $-0.81 | $-0.05 | ||
| Q4 24 | $-0.71 | $-0.24 | ||
| Q3 24 | $-0.73 | $0.05 | ||
| Q2 24 | $-0.55 | $0.11 | ||
| Q1 24 | $-2.35 | $-0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $388.9M | — |
| 总债务越低越好 | — | $279.8M |
| 股东权益账面价值 | $139.1M | $405.9M |
| 总资产 | $480.2M | $823.2M |
| 负债/权益比越低杠杆越低 | — | 0.69× |
8季度趋势，按日历期对齐
现金及短期投资RYTMSWIM
| Q4 25 | $388.9M | — | ||
| Q3 25 | $416.1M | — | ||
| Q2 25 | $291.0M | — | ||
| Q1 25 | $314.5M | — | ||
| Q4 24 | $320.6M | — | ||
| Q3 24 | $298.4M | — | ||
| Q2 24 | $319.1M | — | ||
| Q1 24 | $201.2M | — |
总债务RYTMSWIM
| Q4 25 | — | $279.8M | ||
| Q3 25 | — | $281.1M | ||
| Q2 25 | — | $281.5M | ||
| Q1 25 | — | $306.9M | ||
| Q4 24 | — | $281.5M | ||
| Q3 24 | — | $282.8M | ||
| Q2 24 | — | $282.4M | ||
| Q1 24 | — | $282.8M |
股东权益RYTMSWIM
| Q4 25 | $139.1M | $405.9M | ||
| Q3 25 | $148.8M | $408.4M | ||
| Q2 25 | $-11.9M | $398.4M | ||
| Q1 25 | $18.9M | $381.1M | ||
| Q4 24 | $21.7M | $387.2M | ||
| Q3 24 | $11.2M | $416.6M | ||
| Q2 24 | $39.3M | $408.1M | ||
| Q1 24 | $61.6M | $391.8M |
总资产RYTMSWIM
| Q4 25 | $480.2M | $823.2M | ||
| Q3 25 | $506.9M | $844.4M | ||
| Q2 25 | $372.7M | $822.1M | ||
| Q1 25 | $386.7M | $824.6M | ||
| Q4 24 | $392.3M | $794.2M | ||
| Q3 24 | $363.6M | $853.4M | ||
| Q2 24 | $381.8M | $830.0M | ||
| Q1 24 | $258.7M | $808.6M |
负债/权益比RYTMSWIM
| Q4 25 | — | 0.69× | ||
| Q3 25 | — | 0.69× | ||
| Q2 25 | — | 0.71× | ||
| Q1 25 | — | 0.81× | ||
| Q4 24 | — | 0.73× | ||
| Q3 24 | — | 0.68× | ||
| Q2 24 | — | 0.69× | ||
| Q1 24 | — | 0.72× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-25.4M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | — | $14.1M |
| 自由现金流率自由现金流/营收 | — | 14.1% |
| 资本支出强度资本支出/营收 | — | 9.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $38.0M |
8季度趋势，按日历期对齐
经营现金流RYTMSWIM
| Q4 25 | $-25.4M | $23.3M | ||
| Q3 25 | $-26.6M | $51.0M | ||
| Q2 25 | $-23.3M | $36.0M | ||
| Q1 25 | $-40.4M | $-46.9M | ||
| Q4 24 | $-18.8M | $6.2M | ||
| Q3 24 | $-25.2M | $37.2M | ||
| Q2 24 | $-29.1M | $52.4M | ||
| Q1 24 | $-40.7M | $-34.5M |
自由现金流RYTMSWIM
| Q4 25 | — | $14.1M | ||
| Q3 25 | — | $45.2M | ||
| Q2 25 | — | $29.1M | ||
| Q1 25 | — | $-50.3M | ||
| Q4 24 | — | $-98.0K | ||
| Q3 24 | — | $33.2M | ||
| Q2 24 | — | $47.9M | ||
| Q1 24 | — | $-39.9M |
自由现金流率RYTMSWIM
| Q4 25 | — | 14.1% | ||
| Q3 25 | — | 27.9% | ||
| Q2 25 | — | 16.8% | ||
| Q1 25 | — | -45.2% | ||
| Q4 24 | — | -0.1% | ||
| Q3 24 | — | 22.1% | ||
| Q2 24 | — | 29.9% | ||
| Q1 24 | — | -36.0% |
资本支出强度RYTMSWIM
| Q4 25 | — | 9.2% | ||
| Q3 25 | — | 3.6% | ||
| Q2 25 | — | 4.0% | ||
| Q1 25 | — | 3.1% | ||
| Q4 24 | — | 7.2% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 2.8% | ||
| Q1 24 | — | 4.8% |
现金转化率RYTMSWIM
| Q4 25 | — | — | ||
| Q3 25 | — | 6.29× | ||
| Q2 25 | — | 2.25× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 6.32× | ||
| Q2 24 | — | 3.95× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RYTM
暂无分部数据
SWIM
| In Ground Swimming Pools | $50.2M | 50% |
| Covers | $37.0M | 37% |
| Liners | $12.7M | 13% |
